GB1274820A - Highly attenuated newcastle disease virus vaccine and production thereof - Google Patents
Highly attenuated newcastle disease virus vaccine and production thereofInfo
- Publication number
- GB1274820A GB1274820A GB56463/70A GB5646370A GB1274820A GB 1274820 A GB1274820 A GB 1274820A GB 56463/70 A GB56463/70 A GB 56463/70A GB 5646370 A GB5646370 A GB 5646370A GB 1274820 A GB1274820 A GB 1274820A
- Authority
- GB
- United Kingdom
- Prior art keywords
- virus
- porcine
- newcastle disease
- chick embryo
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
1,274,820. Newcastle disease virus. TAKEDA YAKUHIN KOGYO K.K. 27 Nov., 1970 [29 Nov., 1969], No. 56463/70. Heading A5B. A method of producing an attenuated Newcastle disease vaccine comprises: (1) cultivating Newcastle disease virus either by at least 20 serial passages in a porcine tissue culture or for at least 2 months in porcine stable cell lines to produce porcine cells containing attenuated virus, (2) inoculating this on to the chorioallantoic membrane of a chick embryo and cultivating the chick embryo and (3) recovering the virus from the resulting complex of chorioallantoic membrane and porcine cells and subjecting it to at least 2 serial passages in the allantoic cavity of a chick embryo. The procine tissue culture may contain primary kidney cells. Step (1) may be carried out by persistent infection of porcine stable cell lines with the virus. The virus recovered in step (3) may be further cultivated in a culture containing chick embryo cells to produce the vaccine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9581969 | 1969-11-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1274820A true GB1274820A (en) | 1972-05-17 |
Family
ID=14148007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB56463/70A Expired GB1274820A (en) | 1969-11-29 | 1970-11-27 | Highly attenuated newcastle disease virus vaccine and production thereof |
Country Status (7)
Country | Link |
---|---|
CA (1) | CA962593A (en) |
DE (1) | DE2058645C2 (en) |
DK (1) | DK124340B (en) |
ES (1) | ES385968A1 (en) |
FR (1) | FR2073436B1 (en) |
GB (1) | GB1274820A (en) |
NL (1) | NL170595C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986000811A1 (en) * | 1984-07-30 | 1986-02-13 | Csatary Laszlo | Therapeutic preparations for treatment of certain viral and other diseases and the preparation of the same |
US5124148A (en) * | 1988-04-27 | 1992-06-23 | United Cancer Research Institute | Method for treating viral diseases with attenuated virus |
US7914979B2 (en) | 2004-11-05 | 2011-03-29 | Wellstat Biologics Corporation | Stable and filterable enveloped virus formulations |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU826584A1 (en) * | 1979-10-29 | 1982-11-07 | Всесоюзный государственный научно-контрольный институт ветеринарных препаратов | Vaccine against newcastle fowl disease, process for preparing the same and method for prophylaxis of newcastle fowl diease |
CN102268410B (en) * | 2011-06-17 | 2013-02-27 | 湖北省农业科学院畜牧兽医研究所 | Newcastle disease virus heat-resistant attenuated strain adapted to baby hamster kidney passage cell and preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2767117A (en) * | 1953-10-22 | 1956-10-16 | Crawley John Frederick | Poultry virus vaccine products and method of preparing the same |
GB1010509A (en) * | 1962-02-23 | 1965-11-17 | Pfizer Ltd | Improvements in or relating to newcastle disease virus vaccines |
-
1970
- 1970-11-25 DK DK599270AA patent/DK124340B/en not_active IP Right Cessation
- 1970-11-26 NL NLAANVRAGE7017334,A patent/NL170595C/en not_active IP Right Cessation
- 1970-11-27 CA CA099,281A patent/CA962593A/en not_active Expired
- 1970-11-27 ES ES385968A patent/ES385968A1/en not_active Expired
- 1970-11-27 GB GB56463/70A patent/GB1274820A/en not_active Expired
- 1970-11-28 DE DE2058645A patent/DE2058645C2/en not_active Expired
- 1970-11-30 FR FR7042991A patent/FR2073436B1/fr not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986000811A1 (en) * | 1984-07-30 | 1986-02-13 | Csatary Laszlo | Therapeutic preparations for treatment of certain viral and other diseases and the preparation of the same |
US5124148A (en) * | 1988-04-27 | 1992-06-23 | United Cancer Research Institute | Method for treating viral diseases with attenuated virus |
US7914979B2 (en) | 2004-11-05 | 2011-03-29 | Wellstat Biologics Corporation | Stable and filterable enveloped virus formulations |
Also Published As
Publication number | Publication date |
---|---|
CA962593A (en) | 1975-02-11 |
FR2073436B1 (en) | 1974-08-30 |
ES385968A1 (en) | 1973-11-16 |
FR2073436A1 (en) | 1971-10-01 |
NL7017334A (en) | 1971-06-02 |
DK124340B (en) | 1972-10-09 |
NL170595C (en) | 1982-12-01 |
DE2058645A1 (en) | 1971-06-09 |
NL170595B (en) | 1982-07-01 |
DE2058645C2 (en) | 1982-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Salvin et al. | The enhancement of the virulence of Candida albicans in mice | |
GB1522006A (en) | Feline calicivirus vaccine and a process for the production thereof | |
JPS6237015B2 (en) | ||
GB1274820A (en) | Highly attenuated newcastle disease virus vaccine and production thereof | |
Lepine et al. | Action of chloromycetin and of aureomycin on normal tissue cultures | |
GB1317710A (en) | Poultry vaccine | |
Yunker et al. | Growth of Colorado tick fever (CTF) virus in primary tissue cultures of its vector, Dermacentor andersoni Stiles (Acarina: Ixodidae), with notes on tick tissue culture | |
Findlay | A note on the cultivation of the virus of fowl-pox | |
GB1211246A (en) | Method for producing citric acid by fermentation | |
Grossfeld | Studies on production of hyaluronic acid in tissue culture: The presence of hyaluronidase in embryo extract | |
GB1015262A (en) | Virus culture | |
GB1133958A (en) | Process for the manufacture of a distemper vaccine | |
Vincent et al. | Duration of invasiveness of Entamoeba histolytica maintained in vitro | |
Müller | Influence of ionizing radiation on the appearance in the serum of rabbits of humoral factors slowing down cell division | |
SU611597A3 (en) | Method of cultivating streptococcus hemolyticus | |
Choppin | Effect of actinomycin D and halogenated deoxyuridines on the replication of simian virus 5. | |
Faulkner et al. | Propagation of a strain of rabbit fibroma virus in tissue-culture | |
JPS6434925A (en) | Method for cultivating bordetella pertussis, pertussis toxoid and mixed vaccine thereof | |
US3303094A (en) | Antivirus antibiotic from paecilomyces todicus and method of producing same | |
Burdette | Influence of penicillin on frequency of induced mutations | |
GB1212363A (en) | Process for the preparation of a vaccine against rabies | |
GB1070764A (en) | Improvements in or relating to a process for culturing tissue cells | |
FR2088089A1 (en) | Myxomatosis vaccine - by serial passage in chick embryo then in rabbit kidney cells | |
Brooker et al. | Ciliated fibroblasts in rabbit ear chambers. | |
GB1161414A (en) | Vaccines against Measles and process for their manufacture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |